• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用壳聚糖/小干扰RNA纳米颗粒系统的RNA干扰:体外和体内应用

RNAi using a chitosan/siRNA nanoparticle system: in vitro and in vivo applications.

作者信息

Andersen Morten Østergaard, Howard Kenneth Alan, Kjems Jørgen

机构信息

Interdisciplinary Nanoscience Center (iNANO), Department of Molecular Biology, University of Aarhus, Aarhus C, Denmark.

出版信息

Methods Mol Biol. 2009;555:77-86. doi: 10.1007/978-1-60327-295-7_6.

DOI:10.1007/978-1-60327-295-7_6
PMID:19495689
Abstract

Delivery is a key issue in development of clinically relevant RNAi therapeutics. Polymeric nanoparticles formed by self-assembly of polycations with siRNA can be used for extracellular delivery, cellular uptake and intracellular trafficking as a strategy to improve the therapeutic potential of siRNA. This chapter describes a chitosan-based nanoparticle system for in vitro and in vivo transfection of siRNA into cells. The method exploits the mucoadhesive and mucopermeable properties of this cationic polysaccharide to deliver siRNA across mucosal epithelium and provides a platform for targeting human diseases with RNAi therapeutics.

摘要

递送是临床相关RNAi疗法开发中的一个关键问题。由聚阳离子与siRNA自组装形成的聚合物纳米颗粒可用于细胞外递送、细胞摄取和细胞内运输,作为提高siRNA治疗潜力的一种策略。本章描述了一种基于壳聚糖的纳米颗粒系统,用于在体外和体内将siRNA转染到细胞中。该方法利用这种阳离子多糖的粘膜粘附和粘膜渗透特性,将siRNA递送至粘膜上皮,并为利用RNAi疗法治疗人类疾病提供了一个平台。

相似文献

1
RNAi using a chitosan/siRNA nanoparticle system: in vitro and in vivo applications.使用壳聚糖/小干扰RNA纳米颗粒系统的RNA干扰:体外和体内应用
Methods Mol Biol. 2009;555:77-86. doi: 10.1007/978-1-60327-295-7_6.
2
Delivery of siRNA from lyophilized polymeric surfaces.从冻干聚合物表面递送小干扰RNA。
Biomaterials. 2008 Feb;29(4):506-12. doi: 10.1016/j.biomaterials.2007.10.003. Epub 2007 Oct 24.
3
An inhalable β₂-adrenoceptor ligand-directed guanidinylated chitosan carrier for targeted delivery of siRNA to lung.一种可吸入的β₂-肾上腺素能受体配体导向的胍基化壳聚糖载体,用于将 siRNA 靶向递送至肺部。
J Control Release. 2012 Aug 20;162(1):28-36. doi: 10.1016/j.jconrel.2012.06.005. Epub 2012 Jun 12.
4
Chitosan-based nanoparticles for mucosal delivery of RNAi therapeutics.用于RNAi治疗药物黏膜递送的壳聚糖基纳米颗粒。
Adv Genet. 2014;88:325-52. doi: 10.1016/B978-0-12-800148-6.00011-0.
5
Chitosan as a carrier for targeted delivery of small interfering RNA.壳聚糖作为小干扰 RNA 靶向递送的载体。
Int J Pharm. 2010 Oct 31;399(1-2):1-11. doi: 10.1016/j.ijpharm.2010.08.022. Epub 2010 Aug 21.
6
Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.聚乙烯亚胺在体内 RNAi 介导的基因靶向和 siRNA 递送至肺部中的应用。
Eur J Pharm Biopharm. 2011 Apr;77(3):438-49. doi: 10.1016/j.ejpb.2010.11.007. Epub 2010 Nov 18.
7
Multifunctional polymeric nanoparticles for oral delivery of TNF-α siRNA to macrophages.用于 TNF-α siRNA 口服递送至巨噬细胞的多功能聚合物纳米粒。
Biomaterials. 2013 Apr;34(11):2843-54. doi: 10.1016/j.biomaterials.2013.01.033. Epub 2013 Jan 21.
8
The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.聚合物性质对壳聚糖/小干扰RNA纳米颗粒制剂及基因沉默的影响。
Biomaterials. 2007 Feb;28(6):1280-8. doi: 10.1016/j.biomaterials.2006.11.004.
9
Preparation and characterization of chitosan/polyguluronate nanoparticles for siRNA delivery.用于小干扰RNA递送的壳聚糖/聚古罗糖醛酸纳米颗粒的制备与表征
J Control Release. 2009 Oct 15;139(2):146-52. doi: 10.1016/j.jconrel.2009.06.018. Epub 2009 Jun 28.
10
Ultrafine chitosan nanoparticles as an efficient nucleic acid delivery system targeting neuronal cells.超细微壳聚糖纳米粒作为一种靶向神经元细胞的高效核酸传递系统。
Drug Dev Ind Pharm. 2009 Jun;35(6):719-26. doi: 10.1080/03639040802526789.

引用本文的文献

1
SRA inhibition improves antitumor potency of antigen-targeted chaperone vaccine.SRA 抑制提高了抗原靶向伴侣疫苗的抗肿瘤效力。
Front Immunol. 2023 Jan 30;14:1118781. doi: 10.3389/fimmu.2023.1118781. eCollection 2023.
2
In vivo therapeutic efficacy of TNFα silencing by folate-PEG-chitosan-DEAE/siRNA nanoparticles in arthritic mice.叶酸-聚乙二醇-壳聚糖-二乙氨基乙基/小干扰RNA纳米颗粒对关节炎小鼠体内肿瘤坏死因子α沉默的治疗效果
Int J Nanomedicine. 2018 Jan 12;13:387-402. doi: 10.2147/IJN.S146942. eCollection 2018.
3
Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles.
利用表皮生长因子受体靶向壳聚糖纳米颗粒全身递送Mad2沉默小干扰RNA克服非小细胞肺癌中的顺铂耐药性。
Acta Biomater. 2017 Jan 1;47:71-80. doi: 10.1016/j.actbio.2016.09.045. Epub 2016 Sep 30.
4
Protection and Systemic Translocation of siRNA Following Oral Administration of Chitosan/siRNA Nanoparticles.壳聚糖/siRNA 纳米粒经口服给药后的保护和系统转移。
Mol Ther Nucleic Acids. 2013 Mar 5;2(3):e76. doi: 10.1038/mtna.2013.2.
5
Toward personalized cancer nanomedicine - past, present, and future.迈向个性化癌症纳米医学 - 过去、现在和未来。
Integr Biol (Camb). 2013 Jan;5(1):48-65. doi: 10.1039/c2ib20104f.
6
Delivery of RNAi mediators.RNAi 介质的递送。
Wiley Interdiscip Rev RNA. 2010 Sep-Oct;1(2):341-50. doi: 10.1002/wrna.12. Epub 2010 Jun 3.
7
Knocking down cyclin D1b inhibits breast cancer cell growth and suppresses tumor development in a breast cancer model.敲低细胞周期蛋白 D1b 抑制乳腺癌细胞生长并抑制乳腺癌模型中的肿瘤发展。
Cancer Sci. 2011 Aug;102(8):1537-44. doi: 10.1111/j.1349-7006.2011.01969.x. Epub 2011 May 31.